Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state

被引:227
作者
McGarvey, KM
Fahrner, JA
Greene, E
Martens, J
Jenuwein, T
Baylin, SB
机构
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21231 USA
[3] Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria
关键词
D O I
10.1158/0008-5472.CAN-05-2481
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Histone H3 lysine 9 (H3K9) and lysine 27 (H3K27) trimethylation are properties of stably silenced heterochromatin whereas H3K9 dimethylation (H3K9me2) is important for euchromatic gene repression. In colorectal cancer cells, all of these marks, as well as the key enzymes which establish them, surround the hMLH1 promoter when it is DNA hypermethylated and aberrantly silenced, but are absent when the gene is unmethylated and fully expressed in at euchromatic state. When the aberrantly silenced gene is DNA demethylated and reexpressed following 5-aza-2'-deoxycytidine treatment, H3K9. and H3K9me2 are the only silencing marks that, are lost. A series of other silenced and DNA hypermethylated gene promoters behave identically even when the genes are chronically DNA demethylated and reexpressed after genetic knockout of DNA methyltransferases. Our data indicate that,when transcription of DNA hypermethylated genes is activated in cancer cells, their promoters remain in an environment with certain heterochromatic characteristics. This finding has important implications for the translational goal of reactivating aberrantly silenced cancer genes as a therapeutic maneuver.
引用
收藏
页码:3541 / 3549
页数:9
相关论文
共 48 条
  • [21] Interplay between two epigenetic marks: DNA methylation and histone H3 lysine 9 methylation
    Johnson, LM
    Cao, XF
    Jacobsen, SE
    [J]. CURRENT BIOLOGY, 2002, 12 (16) : 1360 - 1367
  • [22] Cancer epigenetics comes of age
    Jones, PA
    Laird, PW
    [J]. NATURE GENETICS, 1999, 21 (02) : 163 - 167
  • [23] The fundamental role of epigenetic events in cancer
    Jones, PA
    Baylin, SB
    [J]. NATURE REVIEWS GENETICS, 2002, 3 (06) : 415 - 428
  • [24] EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
    Kleer, CG
    Cao, Q
    Varambally, S
    Shen, RL
    Ota, L
    Tomlins, SA
    Ghosh, D
    Sewalt, RGAB
    Otte, AP
    Hayes, DF
    Sabel, MS
    Livant, D
    Weiss, SJ
    Rubin, MA
    Chinnaiyan, AM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) : 11606 - 11611
  • [25] Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer
    Kondo, Y
    Shen, LL
    Issa, JPJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (01) : 206 - 215
  • [26] Histone methylation in transcriptional control
    Kouzarides, T
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (02) : 198 - 209
  • [27] An epigenetic road map for histone lysine methylation
    Lachner, M
    O'Sullivan, RJ
    Jenuwein, T
    [J]. JOURNAL OF CELL SCIENCE, 2003, 116 (11) : 2117 - 2124
  • [28] Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer
    Leu, YW
    Yan, PS
    Fan, MY
    Jin, VX
    Liu, JC
    Curran, EM
    Welshons, WV
    Wei, SH
    Davuluri, RV
    Plass, C
    Nephew, KP
    Huang, THM
    [J]. CANCER RESEARCH, 2004, 64 (22) : 8184 - 8192
  • [29] Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements
    Liang, GG
    Chan, MF
    Tomigahara, Y
    Tsai, YC
    Gonzales, FA
    Li, E
    Laird, PW
    Jones, PA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (02) : 480 - 491
  • [30] HP1 and the dynamics of heterochromatin maintenance
    Maison, C
    Almouzni, G
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (04) : 296 - 304